Web CRG
  1. Home
  2. Industry & Investors
  3. License CRG Technologies
  4. Technology Publisher

License CRG Technologies

Explore our Technology Portfolio

If you are exploring licensing opportunities at the CRG, the TBDO can guide you to a wide range of suitable researchers and their technologies.

Search Results - beate+eckes

1 Results Sort By:
Targeting TANGO-1 as a Treatment for Fibrosis (TARTF)
Collagen secretion inhibition in cell and mouse models of fibrosis Compounds that inhibit the formation of the collagen endoplasmic reticulum (ER)-exit machinery in fibroblasts reducing collagen secretion. They can be used for treating fibrotic diseases by targeting the key, common pathological issue, collagen secretion. Technology: Fibrosis underpins...
Published: 11/11/2024   |   Inventor(s): Vivek Malhotra, Ishier Raote, Thomas Krieg, Beate Eckes, Ines Neundorf
Keywords(s): Dermatology, Fibrosis, Respiratory Tract Diseases
Category(s): Drug Targets & Mechanisms, Therapeutics (Biologics & Compounds)

 

 

Categories

Biotechnology (1)
Diagnostics & Prognostics (1)
Drug Targets & Mechanisms (5)
Life Stock & Agriculture (1)
Methodology (1)
Research Tools (cell lines, mice, kits, ABs, ...) (1)
Therapeutics (Biologics & Compounds) (5)

Featured Technologies

Targeting TANGO-1 as a Treatment for Fibrosis (TARTF)
Fast, Low-Input, Easy and Affordable Chromatin ImmunoPrecipitation (FLEA-ChIP)
Novel Therapeutic Targets for DIPG

Most Popular Keywords

Latest Technologies Published

Novel RNA Binding Protein Targets to Treat Melanoma
Published: 10/4/2024  Updated: 10/28/2024
NudTx: Targeting Cancer Stem Cells
Published: 10/4/2024  Updated: 10/4/2024
Targeting TANGO-1 as a Treatment for Fibrosis (TARTF)
Published: 10/4/2024  Updated: 11/11/2024

Search our database for an up-to-date listing of CRG intellectual property available for licensing